Related Experiment Videos
Immunizations for pediatric transplant patients
1Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York.
Insights
Vaccination is key to preventing infections in transplant patients. Routine and special vaccines, including live-attenuated varicella vaccine, significantly reduce transplant-associated morbidity and mortality.
Area of Science:
- Immunology
- Transplant Medicine
- Infectious Diseases
Background:
- Infection is a primary cause of death and illness in transplant recipients.
- Immunization strategies are crucial for preventing infections in this vulnerable population.
Purpose of the Study:
- To review the application of routine pediatric vaccines (diphtheria-pertussis-tetanus, measles-mumps-rubella) in transplant patients.
- To discuss the use of specialized vaccines (hepatitis B, pneumococcal, influenza) in transplant recipients.
- To evaluate experimental live-attenuated virus vaccines for cytomegalovirus and varicella.
Main Methods:
- Review of existing literature and data on vaccine use in transplant patients.
- Analysis of safety and efficacy data for various vaccines, including live-attenuated viral vaccines.
Main Results:
- Routine pediatric vaccines (diphtheria-pertussis-tetanus, measles-mumps-rubella) present unique challenges in transplant patients.
- Specialized vaccines like hepatitis B, pneumococcal, and influenza are important for this group.
- Live-attenuated varicella vaccine shows promise in preventing varicella-zoster virus infection, with successful administration in immunocompromised children.
Conclusions:
- Immunization is a critical preventive measure against infections in transplant patients.
- Live-attenuated varicella vaccine is highly effective and recommended for preventing varicella-zoster virus infection in transplant recipients.
Abstract:
Infection remains a major cause of morbidity and mortality in transplant patients. Many infections, however, can be successfully prevented by immunization. This presentation reviews the problems associated with, and the questions that arise concerning the use of routine pediatric vaccines, such as diphtheria-pertussis-tetanus (DPT) and measles-mumps-rubella (MMR). It also reviews the use of special vaccines such as hepatitis B, pneumococcal, and influenza vaccines in transplant patients. Data concerning the use of two experimental, live-attenuated virus vaccines, against cytomegalovirus (CMV) and varicella, are discussed. The live-attenuated varicella vaccine can be predicted to decrease the morbidity and mortality of varicella-zoster virus infection in transplant patients. It has already been given successfully to immunocompromised children and is highly effective in the prevention of varicella.